Clinical trial
Moderate Continuous Versus High Interval Intensity Training on Gut Dysbiosis and Glucagon Like Peptide Hormone in Irritable Bowel Syndrome
NCT06408610 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Moderate Continuous Versus High Interval Intensity Training on Gut Dysbiosis and Glucagon Like Peptide Hormone in Irritable Bowel Syndrome
- Lead sponsor
- Cairo University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2024
- Completion date
- May 17, 2025
- Enrollment
- 66 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.